Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Cardiovascular disease in CKD in 2013

Reducing cardiovascular risk—light at the end of the tunnel

Nature Reviews Nephrology volume 10, pages 71–72 (2014)Cite this article

Subjects

During 2013, a meta-analysis provided evidence that cystatin C improves estimated glomerular filtration rate in cardiovascular risk categorization in chronic kidney disease (CKD). Another study showed that low diastolic blood pressure (DBP) is harmful in patients with CKD, challenging the paradigm of treating elevated systolic blood pressure regardless of DBP. Overall, mortality rates in CKD have decreased but further improvement is required.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).

    Article  CAS  PubMed  Google Scholar 

  2. Levey, A. S. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference Report. Kidney Int. 80, 17–28 (2011).

    PubMed  Google Scholar 

  3. Shlipak, M. G. et al. Cystatin C versus creatinine in determining risk based on kidney function. N. Engl. J. Med. 369, 932–943 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chobanian, A. V. et al. National Heart, Lung, and Blood Institute. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 42, 1206–1252 (2003).

    Article  CAS  PubMed  Google Scholar 

  5. Kovesdy, C. P. et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann. Intern. Med. 159, 233–242 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  6. US National Institutes for Health. Clinicaltrials.gov [online], (2013).

  7. Ellam, T. J. & Chico, T. J. Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220, 310–318 (2012).

    Article  CAS  PubMed  Google Scholar 

  8. Chue, C. D. et al. Cardiovascular effects of sevelamer in stage 3 CKD. J. Am. Soc. Nephrol. 24, 842–852 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. U.S. Renal Data System. USRDS 2012 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States [online], (2012).

  10. Mitsnefes, M. M., Laskin, B. L., Dahhou, M., Zhang, X. & Foster, B. J. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1999–2010. JAMA 309, 1921–1929 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Renal Diseases and Hypertension, University of Colorado Denver, 13199 East Montview Boulevard, Suite 495, Aurora, 80045, CO, USA

    Michel Chonchol

  2. Denver Health Medical Center, Denver, 660 Bannock Street, Mail Code 4000, Denver, 80204, CO, USA

    Jessica Kendrick

Authors
  1. Jessica Kendrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michel Chonchol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica Kendrick.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kendrick, J., Chonchol, M. Reducing cardiovascular risk—light at the end of the tunnel. Nat Rev Nephrol 10, 71–72 (2014). https://doi.org/10.1038/nrneph.2013.260

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2013.260

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing